Cannara Biotech Reports Q2 2022 Earnings - Review & Analysis - Wednesday April 27th, 2022 скачать в хорошем качестве

Cannara Biotech Reports Q2 2022 Earnings - Review & Analysis - Wednesday April 27th, 2022

Cannara Biotech Inc. (LOVE) reported their second quarter 2022 financial results today and achieved 4th quarter of consecutive positive adjusted EBITDA. Revenues increased substantially year over year but quarter over quarter was a little lackluster but should improve drastically over the next few quarters with the result of Valleyfield scaling. I discuss my thoughts on the earnings today and my thoughts on the astock leading into the days and weeks ahead. Is the LOVE bottom finally in? Is LOVE a good long term hold and investment? Time to buy LOVE stock? LOVE charting and technical analysis for Tuesday April 27th, 2022. For a 7 day FREE trial to the POW Group community visit: https://pursuitofwealthgroup.com POW Algo Alerts has launched! Visit https://pursuitofwealthgroup.com to learn more and find out about a free trial. POW Group Academy has launched as well! Visit https://pursuitofwealthgroup.com and click on "Academy" link at the top of the page to enroll in our new FREE course! Sponsors: Questrade (Official Partner): https://bit.ly/39d6wNS TradingView: https://bit.ly/399DZsA Uphold: https://bit.ly/2XynPH5 WealthSimple: https://bit.ly/3kQaC5i Shakepay: https://bit.ly/3CiaCkh Ledger Hardware Wallet: https://bit.ly/3lsFTdD iTrustCapital: https://bit.ly/3zyQCbl Yubico Security Key: https://bit.ly/2XnSfew PureVPN: https://billing.purevpn.com/aff.php?a... Unstoppable Domains: https://bit.ly/3AkW42I PrimeXBT: https://bit.ly/3zkqoJw Bybit: https://bit.ly/39d75Hu Binance: https://bit.ly/3lq0KOG #CannaraBiotech, #LOVE, #CannaraEarnings